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Hemoglobin (Hb) disorders, which include thalassemia and Hb variants, are the most frequent clinically significant single gene disorders affecting 7% of the 
world population [1]. Although sickle cell disease and thalassemia 
originally restricted to tropics and subtropics, but in this era due 
to migration, worldwide distribution is noted. To avoid the large 
financial burden to provide optimal treatment to patients and the 
innumerable fatalities of untreated patients, screening is the best cure 
for Hb disorders. Prenatal screening, prospective antenatal screening, 
and community carrier screening were introduced according to the 
World Health Organization (WHO) guideline since 1970 [2]. In 
spite of these, 10,000 newborns are suffering from β-thalassemia 
every year according to the published epidemiological data in India 
[3]. The next step of prevention is the secondary prevention which 
includes early detection by newborn screening to initiate the earliest 
recognition and timely intervention. Recommended interventions 
are genetic counseling, disease education, and antibiotic prophylaxis, 
depending on the diagnosis.
Hb is polypeptide tetramers consisting of two pairs of unlike 
globin chains (α, β, γ, and δ), to each of which is bound a heme 
group. Hb in normal adult human blood is 96% HbA (α2β2), 
2–3% HbA2 (α2δ2), and 1% HbF (α2γ2). However, the normal 
newborn blood contains HbF as the major constituent (60–80%) 
followed by HbA [4]. Hb variants are typically identified from their 
electrophoretic mobility, the quantity of the abnormal Hb, and the 
ethnic background of the individual. The electrophoretic methods, 
still widely used, are declining, given their difficulty of automation 
and inaccurate quantification of minor Hb constituents. High-
performance liquid chromatography (HPLC) is now considered to be 
a sensitive, specific, and reproducible alternative to electrophoresis. 
Capillary electrophoresis is also a versatile analytical electrophoresis 
technique that uses numerous separation principles, including 
isoelectric focusing (IEF). The majority of Hb variants detected in 
any laboratory by investigations for hemoglobinopathies are HbE, β 
thal trait, HbD Punjab, and Hbs [5].
In our study, we aim to evaluate the prevalence of thalassemia 
and other hemoglobinopathies in the study population and 
to develop and compare both resolution and quantification 
capabilities of two methods, suitable for the initial newborn 
screening: IEF and HPLC assay.
ABSTRACT
Introduction: Hemoglobinopathies are the common genetic disorders and are considered as the emerging health burden. To 
reduce the childhood and infant mortality and morbidity, early recognition by newborn screening and timely intervention is 
necessary. Objectives: The objectives of this study are to evaluate the prevalence of different hemoglobinopathies in the study 
population and to compare the efficacy of isoelectric focusing (IEF) and high-performance liquid chromatography (HPLC) tests in 
the neonatal screening for hemoglobinopathies. We have also assessed the predominant mutations for all β-thalassemia variants. 
Materials and Methods: The prospective observational study was conducted in the Department of Pathology in collaboration 
with the Department of Neonatology over 1½ years including 4200 neonates. Both IEF and HPLC diagnoses were attempted 
and compared with recall HPLC and parent HPLC. DNA analysis was also done further confirmation in all thalassemia cases. 
Results: A total of 213 cases with 11 Hb variants were detected; among them, HbE trait was the most prevalent type. Overall 
sensitivity, specificity, and negative and positive predictive values were noted. The results of IEF were comparable with HPLC with 
a statistically significant measure of agreement of κ=0.928 between the two. DNA analysis of 37 β-thalassemia variants revealed 
three common mutations, i.e., cd26 (G>A), IVS1-5 (G>C), and cd15 (G>A). Conclusion: In IEF, the hemoglobin separation is very 
precise with little band overlap, but the process and interpretation need a high expertise. Due to more sensitivity, IEF should be the 
initial screening test followed by recall HPLC for confirmation of the diagnosis.
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MATERIALS AND METHODS
This prospective and observational study was conducted in the 
Department of Pathology in collaboration with the Department 
of Neonatology during January, 2012–July, 2013. Catchment 
areas were West Bengal and neighboring states (Jharkhand, 
Bihar, Orissa, and Northeast states) because our hospital was a 
tertiary care referral center. Prior approval from the institutional 
ethics committee was obtained. IEF was carried out as primary 
screening program using dried blood sample by heel puncture on 
filter papers, followed by HPLC in ethylenediaminetetraacetic 
acid (EDTA) blood. Based on the initial screening findings, recall 
HPLC of both infants and parents was further analyzed.
After taking written consent from the parents, dried blood 
spot samples were obtained from 4200 neonates by heel puncture 
within 3–7 days of age. Inclusion criteria were (1) non-premature 
neonates, (2) informed consent from parents, and (3) participants 
who had no history of blood transfusion at the time of sample 
collection. The pre-analytical parameters were assessed; complete 
Hb parameter was measured using 3-ml EDTA blood for study 
population using automated Hb analyzer ((KX-21, Sysmex 
Corporation, Japan). Red cell morphology and platelet counts 
were cross-checked with well-prepared peripheral blood films.
IEF (PerkinElmer, Finland) was employed to detect Hb variant 
in neonatal screening. RESOLVE® test kits and equipment, together 
with the IsoScan® Digital Imaging System, was used to detect Hb 
variants in blood spot samples. PerkinElmer RESOLVE® System 
consists of Multiphor II Electrophoresis unit, circulating water bath 
to provide constant temperature control to the electrophoresis unit 
and programmable power supply. Well number for each specimen 
was allocated and 3 mm hole, from dried blood spot, was placed 
in the corresponding well using manual puncher. An amount of 
80 μl Hb elution solution was added followed by wait for 30 min 
at room temperature. The preparation and separation of Hb were 
accomplished through the application of a hemolysate onto a pre-
cast agarose gel, composed of low molecular weight ampholytes 
with isoelectric points between pH 6 and 8. When electrical current 
was applied to the gel, these molecules migrate to their isoelectric 
points (pI) within the gel, forming a stable pH gradient. The Hb 
variants also migrated through the pH gradient in the gel until the 
pI of the individual variant equals the corresponding pH of the 
gel. When the net charges on the variants were zero, the migration 
ceased. The Hb variants formed a discrete thin band. JB-2 staining 
system was used for staining of the gel. Results were generated 
as individual reports for all samples, listing percentage, pI, and 
comments using the Iso Scan Imaging System.
Hb was reported in decreasing order of concentration. FA, 
FE, FC, FD, and FAV reporting tables were made and analyzed 
accordingly. HbA% between 5% and 12% was considered as 
β-thalassemia trait in non-premature newborns and <5% for 
thalassemia major and intermedia [6]. Differentiation of major 
and intermedia was done depending on clinical presentation and 
pre-analytical red blood cells indices.
In this study, we employed HPLC to validate and tally the 
results of IEF to find out the positive predictive values between 
the 2 exclusive between 3 and 7 days of age. During recall HPLC, 
215 abnormal cases and 54 normal cases were found but suspected 
for parent’s history were analyzed. We recruited these data from 
the age between 60 and 90 days. The data were assembled by the 
Clinical Data Management software (Bio-Rad Laboratories), and a 
chromatogram was prepared. Manufacturer-assigned windows for 
Bio-Rad Variant II HPLC system help in the interpretation of the 
chromatogram; parent’s HPLC was incorporated in abnormal cases.
Molecular analysis at DNA level was done as an additional 
diagnostic tool in all β-thalassemia variants and α-thalassemia. 
The DNA was extracted from the blood samples collected from 
the newborns and their respective parents when they came back 
to the hospital for recall and follow-ups in 37 cases and 5 cases 
of α-thalassemia. 1 case of HbS-β-thalassemia and 4 cases of 
β-thalassemia trait were lost to follow-up. Technicians collected 
3 ml of blood from the individuals and further extracted DNA 
by phenol extraction method using a standard procedure [7]. The 
DNA-based diagnosis was performed following the methods 
adopted by Old, 2001 [8], and direct sequencing of hemoglobin 
beta HBB gene through ABI-3730 DNA analyzer.
The reports of initial IEF and initial HPLC were statistically 
analyzed based on recall HPLC and parent HPLC using Chi-
square test, Matthews correlation test, sensitivity, specificity, 
positive predictive value, negative predictive value, and 
diagnostic accuracy. Software used in statistical analysis of our 
study was MedCalc version 11.6 (Mariakerke, Belgium: MedCalc 
Software 2011).
RESULTS
Among 4200 neonates in this study, we identified a total 
of 213 cases of hemoglobinopathies consisting of 11 Hb 
variants (Figs. 1-4) named as HbE, β-Thal Carrier (β+), β-Thal 
intermediate, HbD Punjab, HbS, β-Thal Major (β0), HbE/β, 
HbD/β (Hetero), α-thalassemia, sickle β, and HbEE disease. We 
observed that HbE trait was quite prominent in this region as it 
was seen in 3.54% within our targeted population and 69.95% 
among the total Hb variants.
Comparison between IEF and HPLC was also performed. The 
test group comprised of 215 abnormal cases, which were detected 
by initial IEF, and control groups comprised of 54 normal cases 
but suspected on the basis of parent’s history. In 269 cases, initial 
IEF and HPLC diagnoses were attempted and compared with 
Figure 1: Bar diagram showing major hemoglobinopathies 
Vol 5 | Issue 9 | September 2018 Indian J Child Health 568
Kumar et al. Role of IEF and HPLC in screening of hemoglobinopathies in newborns
recall HPLC and parent HPLC. The results are shown in Table 1. 
Complete correlation between IEF and HPLC was obtained in the 
diagnosis of thalassemia major (6 cases, 2.81%). There were seven 
cases of Hb E-β detected by IEF and subsequently confirmed by 
HPLC. When detecting HbD- β and HbS-β-thalassemia, HPLC 
was successful in 100% of cases detected by IEF.
Major discrepancies were noted in β-thalassemia intermedia 
(3 cases, 0.46%). Initial HPLC was able to detect 1 of 3 double 
heterozygous conditions observed by initial IEF. Chromatograms 
in two cases were unremarkable. Combination of recall HPLC, 
parent study, and molecular finding confirmed all three cases of 
β-thalassemia intermedia. During initial IEF and HPLC, 26 and 24 
neonates were suspected, respectively to have β-thalassemia trait 
depending on the low-intensity band of HbA compared to normal 
newborns. However, by recall HPLC of suspected cases and 
parents, only 24 cases were diagnosed and confirmed by further 
genetic study. A significant drop in the diagnostic accuracy of 
HPLC was observed in α-thalassemia. It was identified in 5 cases 
and 2 cases of the samples tested by IEF and HPLC, respectively. 
Early eluting peak was detected in HPLC chromatogram in two 
cases of α-thalassemia. Another 3 cases which were positive 
in IEF remain undetectable in HPLC probably due to the low 
concentration of HbH.
No major discrepancies were noted in the initial presumptive 
diagnosis of other hemoglobinopathies. The most common 
neonatal hemoglobinopathy in our study was sickle cell disease 
(10 cases, 4.69%), followed by Hb D-Punjab (5 cases, 2.34%). 
An abnormality was detected in HPLC chromatogram in all cases 
of Hb E homozygous (2 cases, 0.93%) detected by IEF revealing 
significant correlation (100%). The common phenotype in the 
present study was HbE trait (149 cases, 69.9%). All cases of HbE 
trait were confirmed to have Hb abnormalities by both HPLC and 
IEF during neonatal screening.
Evaluation of first line of screening was done, and we 
documented our experience using IEF and HPLC as the 
initial newborn screening technique for thalassemia and other 
hemoglobinopathies. Eleven Hb variants were identified by 
both the techniques, with no discrepancy in the detection of 
variants. Overall sensitivity, specificity, and negative and positive 
predictive values were shown in Table 2. The results of IEF were 
comparable with HPLC with a statistically significant measure of 
agreement of κ = 0.928 between the two.
We have also conducted DNA analysis of 37 β-thalassemia 
variants for three common mutations found in Asian Indian 
population, i.e., cd26 (G>A), IVS1-5 (G>C), and cd15 (G>A). 
The occurrence of these three mutations was seen in a total of 
36 cases (87.8%). IVS 1-5 (G>C) was found in 68.3% of cases, 
cd15 (TGG>TAG) in 21.95% of cases, and cd26 (G>A) was 
found in 19.5% of cases.
DISCUSSION
Hb disorders are considered to be a serious health problem by the 
WHO. In India, the carrier frequency of β-thalassemia varies from 
1 to 17% (mean 3.3%). In the present study, on 4200 patients, 
213 (5.07%) cases were found to have hemoglobinopathies. 
Although HbE trait was the most common (149 cases, 3.54%) 
hemoglobinopathies in this study group, it is very closely followed 
by β-Thal trait (24 cases, 0.57%). There are very few studies from 
West Bengal which evaluated the prevalence of thalassemia and 
various hemoglobinopathies. Dolai et al. [9] conducted a large 
HPLC-based study on 35,413 participants from rural Bengal. 
β-Thal trait was found in 10.38%, HbE carrier in 4.30%, and sickle 
cell trait in 1.12% of cases. In another study from West Bengal, Jain 
et al. [10] observed that overall 29.3% of subjects were positive 
for hemoglobinopathies. β-Thal trait was appeared to be the most 
common hemoglobinopathies in their study followed by HbE 
heterozygous. In similar study conducted over 3 years in Kolkata 
on 10,407 participants, 1,509 (14.5%) cases had abnormal Hb 
fractions. Although β-Thal trait was the most common (579 cases, 
5.6%) hemoglobinopathy in this study group, it was very closely 
(522 cases, 5.0%), followed by HbE carrier [11].
Figure 2: Distribution of other hemoglobinopathies
Figure 3: High-performance liquid chromatography curves
Figure 4: Isoelectric focusing pattern
Vol 5 | Issue 9 | September 2018 Indian J Child Health 569
Kumar et al. Role of IEF and HPLC in screening of hemoglobinopathies in newborns
The aim of this was early detection of the Hb disorders to 
reduce infant morbidity and mortality significantly in the neonatal 
stage. Early detection helps the clinicians and parents of the 
affected babies to reach to a decision for early treatment plan such 
as infants with sickle cell disease must receive prompt follow-up, 
oral penicillin prophylaxis, and immunizations. Early detection of 
non-sickle hemoglobinopathies helps in the initiation of prompt 
delivery of care before the development of clinical complication. 
Rationality of newborn screening is supported by availability 
of curative measures like stem cell transplantation nowadays. 
Parental counseling based on the risk of having next child and 
education regarding prevention of complication in diseased child 
is another advantage of the integration of newborn screening. The 
study confirmed hemoglobinopathies in 213 cases and normal Hb 
in 3987 cases. The results of IEF were comparable with HPLC 
with a significant measure of agreement of κ = 0.928 between 
the two. We highlight certain advantages of IEF over HPLC in 
the diagnosis of hemoglobinopathies; the first was excellent Hb 
separation with very little band overlap.
Normal interpretation of results with HPLC reports in double 
heterozygous Hb variants was detected due to band overlapping in 
our study. Some Hbs coelute in the HbA2 window, like HbE, made it 
impossible to measure HbA2 in the presence of these hemoglobins 
[12]. In the presence of HbS, HPLC gives falsely increased HbA2 
levels, and in HbD, HbA2 is falsely reduced due to an integration 
error [13,14]. On the other hand, HbA2 and HbE migrate together 
in IEF like HPLC, but it is noticeable by their appearance and 
percentage; hence, we marked a cutoff line to report as follows: 
If the relative percentage <7% is HbA2 or higher than >10% 
could be reported as HbE with a clear dark visible band on the gel. 
Subsequently, distinguish between HbS and HbD Punjab is quite 
accurate due to their clear view of little distance between the two 
bands of the variants in IEF. Hempe and Craver [15] showed the 
excellent role of IEF in neonatal hemoglobinopathies. According 
to their study, high-resolution separation and quantification of 
the major and minor Hb variants are possible by IEF. Mario et al. 
[16] stated similar conclusion. Campbell et al. [17] demonstrated 
false negative reporting by HPLC in case of double heterozygous 
during neonatal screening which is similar to our study.
In our study, we also observed one more advantage of IEF, 
i.e., accurate detection of α-thalassemia. IEF was more sensitive 
than HPLC in case of α-thalassemia detection. By protocol, 
HbH is identified when there are three gene deletions, as HPLC 
chromatogram demonstrates detectable early eluting peak in > 5% 
concentration of HbH. In low concentration (<2%), IEF focusing 
was successful [18]. In spite of the following advantages, we 
encountered increased figures of false positive report in IEF 
during detection and evaluation of β-thalassemia traits in the early 
stage of this study, which was recovered later.
In the present study, DNA analysis has been done on 
37 β-thalassemia variant for three common mutations. Among 
them, IVS1-5 (G>C) is the most common, found in 68.3% of cases, 
followed by cd15 (G>A) in 21.95% and cd26 (G.A) in 19.5% of 
cases. Ayub et al. [19] conducted a research to see thalassemia 
mutations in the Bangladeshi population. In this analysis of 587 bp 
of the HBB gene, splice junction mutation IVS-I-5 was the most 
common mutation. Gupta et al. [20] conducted a DNA analysis 
in 385 carriers for 5 β-thalassemia mutations. The occurrence of 
these 5 mutations was seen in 299 (91.2%) carriers. They found 
Cd16 (-C) in 2.1%, CD30 (G-C) in 1.5%, and CD 15(G-A) in 0.6% 
which are considered common mutations in the Indian population.
CONCLUSION
The present study revealed that both IEF and HPLC have their 
own advantages and disadvantages. In IEF, the Hb separation 
is very precise with a very little band overlap, but the process 
and interpretation need a high expertise, whereas HPLC is very 
compact and user-friendly. Although IEF and HPLC both are 
labor saving and objective screening tool for early detection and 
management of hemoglobinopathies, IEF should be the initial 
screening test due to more sensitivity followed by recall HPLC 
for confirmation and help to take decision regarding treatment
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